CA - XORTX appoints James Fairbairn as Interim CFO
2023-06-29 12:19:43 ET
- In its annual and special meeting of shareholders held on Wednesday, June 28, 2023, XORTX Therapeutics ( NASDAQ: XRTX ) announces appointment James Fairbairn as Interim CFO.
- Source: Press Release
For further details see:
XORTX appoints James Fairbairn as Interim CFO